Position in SNY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,424,844
New position
Shares Held
33,400
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#218
of 712 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. holds $30,306,066 across 7 Drug Manufacturers - General names. SNY ranks #7 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
80,000 | $10,107,200 | |
| 2 | AZN |
Astrazeneca PLC
|
30,000 | $5,688,600 | |
| 3 | JNJ |
Johnson & Johnson
|
18,300 | $4,647,651 | |
| 4 | MRK |
Merck & Co., Inc.
|
31,173 | $4,005,730 | |
| 5 | NVS |
Novartis AG
|
16,800 | $2,632,896 | |
| 6 | LLY |
ELI LILLY & Co
|
1,500 | $1,799,145 | |
| 7 | SNY |
Sanofi
This page
|
33,400 | $1,424,844 |
All Filings in SNY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,424,844 | 33,400 | Shares | Defined | 2026-07-23 | |
| No filing history on record for this holder in this stock. | ||||||